4 Cipla Ltd — Persistent Overview Cipla Ltd is a leading Indian multinational pharmaceutical and healthcare company known for its broad portfolio of generic medicines and specialty therapies. Cipla has a strong focus on affordable, high-quality medicines, with significant presence in both domestic and international markets across acute, chronic, and specialty therapeutic areas. Core Business Model 1️⃣ Pharmaceutical Formulations Wide range of generic drugs across therapeutic categories such as respiratory, cardiovascular, anti-infectives, oncology, and HIV/AIDS. Focus on accessible and cost-effective treatments. 2️⃣ Specialty and Complex Generics Increasing emphasis on complex, high-value products, including inhalers and biosimilars. Investments in R&D and regulatory approvals to access developed market opportunities. 3️⃣ Global Footprint Operations in multiple international markets, with strong presence in Africa, South Asia, and regulated markets. Export-oriented business supporting diversification. Competitive Strengths 1️⃣ Diversified Portfolio Cipla’s wide therapeutic exposure helps reduce concentration risk and tap into chronic and high-growth segments. 2️⃣ Established Global Presence Strong distribution and regulatory experience in emerging and developed markets enhances market reach. 3️⃣ R&D and Complex Product Focus Investment in complex generics and specialty products supports premiumisation and margin expansion. 4️⃣ Affordable Healthcare Position Cipla’s historic emphasis on accessibility positions it well in both price-sensitive and regulated markets.